Pharm Drug Names Flashcards
citalopram
SSRI for depression
escitalopram
SSRI for depression
fluoxetine
SSRI for depression, premenstrual dysphoric disorder
fluvoxamine
SSRI for depression
paroxetine
SSRI for depression
sertraline
SSRI for depression, esp. for elderly
duloxetine
SNRI for depression, GAD, and other pain disorders
venlafaxine
SNRI for MDD, GAD, panic disorder, social phobias
desvenlafaxine
SNRI for MDD, GAD, etc.
levomilnacipran ER
SNRI for MDD, GAD, etc.
phenelzine
MAOI non-selective, irreversible
tranylcypromine
MAOI non-selective, irreversible
isocarboxazid
MAOI non-selective, irreversible
amitriptyline
TCA tertiary amine
clomipramine
TCA tertiary amine
imipramine
TCA tertiary amine
doxepin
TCA tertiary amine
desipramine
TCA secondary amine
nortriptyline
TCA secondary amine
bupropion (wellbutrin)
misc. antidepressant indicated for MDD with a less sexual dysfunction SDE
mirtazapine
misc. antidepressant with low doses being the most sedating
trazodone
misc. antidepressant that is not FDA approved for insomnia, but commonly used for this
priapism SED
nefazodone
misc. antidepressant FDA indicated for depression and strong life-threatening liver failure black box warning
vilazodone
misc. antidepressant good for when partial/incomplete response to SSRI’s/SNRI’s
vortioxetine
misc. antidepressant effective in tx of cognitive dysfunction in patients with MDD
bupropion (zyban)
nicotine cessation drug that doubles the likelihood of quitting as compared to placebo
hypersensitivity reactions are an ADE
varenicline
nicotine cessation drug superior to bupropion and nicotine replacement
reduced in severe renal impairment
nicotine replacement formulations
transdermal
gum
nasal spray
inhaler
morphine
opioid receptor agonist
hydromorphone
opioid receptor agonist
codeine
opioid receptor agonist
hydrocodone
opioid receptor agonist
oxycodone
opioid receptor agonist
meperidine
opioid receptor agonist
fentanyl
opioid receptor agonist
methadone
opioid receptor agonist
naloxone
opioid receptor antagonist
naltrexone
opioid receptor antagonist
methylnaltrexone
opioid receptor antagonist
buprenorphine
opioid partial agonist
tramadol
opioid partial agonist
major ADE of benzodiazepines
anterograde amnesia
alprazolam
short, fast acting benzo for anxiety, GAD, panic
chlordiazepoxide
long, fast acting benzo for preventing seizures in patients undergoing alcohol detox, anxiety
clonazepam
fast, moderate acting benzo for quick, short, intermittent use
similar to alprazolam
diazepam
fast, long acting benzo good for anxiety and preventing seizures in alcohol detox
lorazepam
fast, short-med. acting benzo used for anxiety, insomnia, sedation induction, status epilepticus
good for elderly/renal impaired
midazolam
rapid, very short acting benzo for general anesthesia induction and maintenance, sedation maintenance
triazolam
fast, short acting benzo for insomnia and only insomnia
flumazenil
ultra, rapid very short acting benzo for the reversal of sedation of benzos
benzo OD
pentobarbital
barbiturate used for pre-anesthetic sedation, various anti-seizure uses
phenobartbital
barbiturate used for many kinds of seizures, short-term insomnia, sedation, anxiety, apprehension
zolpidem
sleep drug causing severe morning grogginess
eszopiclone
sleep drug used for insomnia
zaleplon
sleep drug used short term insomnia
diphenhydramine
antihistamine for other sedative/hypnotics
doxepin
TCA for other sedative/hypnotics
ramelteon
melatonin receptor agonist for other sedative/hypnotics
buspirone
non-benzo anti-anxiety med
haloperidol
high potency typical antipsychotic
ADE acute dystonia, parkinsonism, tardive dyskinesia
fluphenazine
high potency typical antipsychotic
chlorpormazine
low potency typical antipsychotic
thioridazine
low potency typical antipsychotic
olanzapine
atypical antipsychotic group 1
risperidone
atypical antipsychotic group 1 - neuroleptic malignant syndrome
paliperidone
atypical antipsychotic group 1
iloperidone
atypical antipsychotic group 1
quetiapine
atypical antipsychotic group 1
clozapine
atypical antipsychotic group 1 - agranulocytosis
atypical antipsychotic group 1
STRONG ADE of metabolic effects
Weight gain
Worsening of a lipid profile
Increased risk of DB and CV dx
Atypical antipsychotics group 2
Used to treat bipolar (preventing mania) more so than schizophrenia
second generation with less movement disorders
ziprasidone
Atypical antipsychotics group 2
aripiprazole
Atypical antipsychotics group 2
lurasidone
Atypical antipsychotics group 2
More atypical antipsychotics
second generation with less movement disorders
asenapine
More atypical antipsychotics
iloperidone
More atypical antipsychotics
brexpiprazole
More atypical antipsychotics
cariprazine
More atypical antipsychotics
valproate
anticonvulsant mood stabilizer
lamotrigine
mood stabilizer that can cause Steven-Johnson syndrome
carbamazepine
anticonvulsant mood stabilizer
lithium
started in acute manic phase of bipolar disorders
not an antipsychotic = NO schizo treatment